Diagnostic tech developer Masimo (NSDQ:MASI) and rival Dominion have settled a suit over blood monitoring patents, according to recently released court documents.

The two companies said they reached a settlement deal over a suit brought against Masimo by Dominion claiming it infringed on patents related to noninvasive blood monitoring technology.

The agreement does not include payments from either company, and leaves both sides to pay for their own legal costs, according to court documents.

The settlement deal was signed by US District Judge Beth Freeman on Tuesday.

Earlier this week, Masimo released results from a study exploring home pulse oximetry monitoring’s ability to serve as an initial screening method to determine which children with Down syndrome should be recommended to undergo sleep studies to diagnose obstructive sleep apnea.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW